Form 4 for ABT Abbott Laboratories
Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001415889-23-003908 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-02 | 2023-03-01 | ABT | Ginascol John F | EVP | S - Sale | $100.70 | -943 | 118.4K | -0.8% | -$95.0K | |
| 2023-03-02 | 2023-02-28 | ABT | Ginascol John F | EVP | F - Tax | $99.77 | -6,859 | 119.3K | -5% | -$684.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2023-03-01 | S | D | 943 | $100.70 | 118,380 | D | — | — | |
| 2 | Common | Common shares without par value | 2023-02-28 | F | D | 6,859 | $99.77 | 119,323 | D | — | — |